Commission incorporates Parliament views in revised FP7 proposal

The European Commission has adopted an amended proposal for the Seventh Framework Programme (FP7), which seeks to incorporate amendments made by the European Parliament and the Council of Ministers in their first readings. The Commission reports that the revised proposals "take up in spirit and content if not necessarily always with the exact wording, to a large proportion the position taken by the other institutions".

The Commission adopted its original FP7 proposal in April 2005, while the budgetary aspects to the programme were adopted in May 2006, following agreement on the EU's Financial Perspectives for 2007 to 2013. The Parliament adopted the proposals by a broad majority in June 2006, proposing some 1700 amendments.

The themes set to receive funding under the Cooperation programme remain the same, with a number of clarifications, specifying areas in which research will be funded. These range from healthy ageing and infectious diseases to soil fertility, the sustainability of fisheries, platforms for software and services and nano-composites.

On Joint Technology Initiatives (JTIs), long-term public-private partnerships to boost technology in specific fields, the Commission accepts modifications on the criteria to be used for identifying potential JTIs, as well as their organisation and implementation.

For example, the new proposal adds that when assessing the need for a JTI: the existence of a genuine societal need and benefit; the scale of the impact on industrial competitiveness and growth; and the inability of existing instruments to achieve the objective should all be taken into account.

The amended proposal also emphasises that small and medium sized enterprises (SMEs), technology transfer and education should not be neglected by JTIs. The organisation of JTIs should ensure that "participation in their projects is open to a wide range of participants throughout Europe, and in particular SMEs".

The Commission also incorporates important clarifications on the European Research Council (ERC), and in particular on the term of office, the renewal and the role of the Scientific Council, the management and staffing arrangements, and the independent review of the ERC.

MEPs had requested a review of the ERC in 2008. Speaking to the Parliament during a debate on FP7, EU Science and Research Commissioner Janez Potocnik suggested that this would be too soon. The revised proposal states that the review will be carried out 'no later than 2010'.

The new document adds that the ERC shall have the ability to conduct its own strategic studies to prepare and support its operational activities.

Ethics were a major consideration for many parliamentarians, and the revised proposal seeks to allay concerns by specifying which areas will not receive any funding under FP7. These are human cloning for reproductive purposes, research intended to modify the genetic heritage of human beings which could make such changes heritable, and research intended to create human embryos solely for the purpose of research or the purpose of stem cell procurement.

To follow the debate on FP7, please visit:

http://cordis.europa.eu/fp7/home.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...